| Cufence 100 mg hard capsule EU/1/19/1365/001 |
TRIENTINE DIHYDROCHLORIDE |
Univar B.V |
— |
| Cuprior 150 mg film-coated tablets EU/1/17/1199/001 |
Trientine tetrahydrochloride |
gmp-orphan SA |
— |
| Cuprymina 925 MBq/mL radiopharmaceutical precursor, solution EU/1/12/784/001 |
Copper (64 cu) chloride |
A.C.O.M. Advanced Center Oncology Macerata S.r.l. |
— |
| CUROSURF 120 mg/vial Endotracheopulmonary instillation, suspension PA0584/005/001 |
Porcine lung surfactant |
Chiesi Farmaceutici S.p.A. |
Marketed |
| CUROSURF 240 mg/vial Endotracheopulmonary instillation, suspension PA0584/005/002 |
Porcine lung surfactant |
Chiesi Farmaceutici S.p.A. |
Marketed |
| Cyanokit 2.5 g Powder for solution for infusion EU/1/07/420/001 |
Hydroxocobalamin |
SERB S.A. |
— |
| Cyanokit 5 g Powder for solution for infusion EU/1/07/420/002 |
Hydroxocobalamin |
Merck Sante s.a.s. |
— |
| Cyclolux 0.5 mmol/ml solution for injection PA23317/001/001 |
Gadoteric acid |
Sanochemia Pharmazeutika GmbH |
Not marketed |
| Cyclophosphamide Seacross 1000 mg powder for solution for injection/infusion PA22766/013/003 |
Cyclophosphamide monohydrate |
Seacross Pharma (Europe) Limited |
Not marketed |
| Cyclophosphamide Seacross 200 mg powder for solution for injection/infusion PA22766/013/001 |
Cyclophosphamide monohydrate |
Seacross Pharma (Europe) Limited |
Not marketed |
| Cyclophosphamide Seacross 2000 mg powder for solution for injection/infusion PA22766/013/004 |
Cyclophosphamide monohydrate |
Seacross Pharma (Europe) Limited |
Not marketed |
| Cyclophosphamide Seacross 500 mg powder for solution for injection/infusion PA22766/013/002 |
Cyclophosphamide monohydrate |
Seacross Pharma (Europe) Limited |
Not marketed |
| Cyklokapron 500 mg Film-coated Tablets PA23355/035/001 |
TRANEXAMIC ACID PH. EUR. |
Viatris Healthcare Limited |
Marketed |
| Cymbalta 30 mg hard gastro-resistant capsules EU/1/04/296/1-4 |
Duloxetine hydrochloride |
Eli Lilly Nederland B.V. |
— |
| Cymbalta 60 mg hard gastro-resistant capsules EU/1/04/296/002-005 |
Duloxetine |
Eli Lilly Nederland B.V. |
— |
| Cyramza 10 mg/ml Concentrate for solution for infusion EU/1/14/957/001-003 |
Ramucirumab |
Eli Lilly Nederland B.V. |
— |
| Cystadane 1g oral powder EU/1/06/379/001 |
Betaine anhydrous |
Recordati Rare Diseases |
— |
| Cystadrops 3.8 mg/mL eye drops solution EU/1/15/1049/001-002 |
Mercaptamine hydrochloride |
Recordati Rare Diseases |
— |
| CYSTAGON 150 mg hard capsules EU/1/97/039/003 |
Mercaptamine bitartrate |
Recordati Rare Diseases |
— |
| CYSTAGON 150 mg hard capsules EU/1/97/039/004 |
Mercaptamine bitartrate |
Recordati Rare Diseases |
— |
| CYSTAGON 50 mg hard capsules EU/1/97/039/001 |
Mercaptamine bitartrate |
Recordati Rare Diseases |
— |
| CYSTAGON 50 mg hard capsules EU/1/97/039/002 |
Mercaptamine bitartrate |
Recordati Rare Diseases |
— |
| Cytarabine 100 mg/ml Solution for Injection or Infusion PA2059/034/001 |
Cytarabine |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Dabigatran etexilate Accord 110 mg hard capsules EU/1/22/1665/007-016 |
Dabigatran etexilate mesilate |
Accord Healthcare S.L.U. |
— |
| Dabigatran etexilate Accord 150 mg hard capsules EU/1/22/1665/017-024 |
Dabigatran etexilate mesilate |
Accord Healthcare S.L.U. |
— |
| Dabigatran etexilate Accord 75 mg hard capsules EU/1/22/1665/001-006 |
Dabigatran etexilate mesilate |
Accord Healthcare S.L.U. |
— |
| Dabigatran etexilate Rowa 110 mg hard capsules PA0074/095/001 |
Dabigatran etexilate mesilate |
Rowa Pharmaceuticals Limited, |
Not marketed |
| Dabigatran etexilate Rowa 150 mg hard capsules PA0074/095/002 |
Dabigatran etexilate mesilate |
Rowa Pharmaceuticals Limited, |
Not marketed |
| Dabigatran etexilate Teva 110 mg hard capsules EU/1/23/1769/007-015 |
Dabigatran etexilate mesilate |
TEVA GmbH |
— |
| Dabigatran etexilate Teva 150 mg hard capsules EU/1/23/1769/016-023 |
Dabigatran etexilate mesilate |
TEVA GmbH |
— |
| Dabigatran etexilate Teva 75 mg hard capsules EU/1/23/1769/001-006 |
Dabigatran etexilate mesilate |
TEVA GmbH |
— |
| Dacogen 50 mg powder for concentrate for solution for infusion EU/1/12/792/001 |
Decitabine |
Janssen-Cilag International NV |
— |
| Dafiro 10 mg/160 mg film-coated tablets EU/1/06/371/017-024 |
Valsartan, Amlodipine besilate |
Novartis Europharm Limited |
— |
| Dafiro 5 mg/160 mg film-coated tablets EU/1/06/371/009-016 |
Amlodipine besilate, Valsartan |
Novartis Europharm Limited |
— |
| Dafiro 5 mg/80 mg film-coated tablets EU/1/06/371/001-008 |
Amlodipine besilate, Valsartan |
Novartis Europharm Limited |
— |
| Dafiro HCT 10 mg/160 mg/12.5 mg film-coated tablets EU/1/09/574/13-24 |
Hydrochlorothiazide, Valsartan, Amlodipine besilate |
Novartis Europharm Limited |
— |
| Dafiro HCT 10 mg/160 mg/25 mg film-coated tablets EU/1/09/574/37-48 |
Hydrochlorothiazide, Valsartan, Amlodipine besilate |
Novartis Europharm Limited |
— |
| Dafiro HCT 10 mg/320 mg/25 mg film-coated tablets EU/1/09/574/49-60 |
Valsartan, Hydrochlorothiazide, Amlodipine besilate |
Novartis Europharm Limited |
— |
| Dafiro HCT 5 mg/160 mg/12.5 mg film-coated tablets EU/1/09/574/1-12 |
Amlodipine besilate, Hydrochlorothiazide, Valsartan |
Novartis Europharm Limited |
— |
| Dafiro HCT 5 mg/160 mg/25 mg film-coated tablets EU/1/09/574/25-36 |
Amlodipine besilate, Hydrochlorothiazide, Valsartan |
Novartis Europharm Limited |
— |
| Dalacin C 150 mg Hard Capsules PPA23080/008/001 |
Clindamycin |
Merit Pharmaceuticals Limited |
— |
| Dapagliflozin MSN 10 mg film-coated tablets PA23250/020/002 |
Dapagliflozin |
MSN Labs Europe Limited |
Not marketed |
| Dapagliflozin MSN 5 mg film-coated tablets PA23250/020/001 |
Dapagliflozin |
MSN Labs Europe Limited |
Not marketed |
| Dapagliflozin Viatris 10 mg Film-coated tablet EU/1/23/1721/013-024 |
Dapagliflozin |
Viatris Limited |
— |
| Dapagliflozin Viatris 5 mg Film-coated tablet EU/1/23/1721/001-012 |
Dapagliflozin |
Viatris Limited |
— |
| Daptomycin Hospira 350 mg powder for solution for injection/infusion EU/1/17/1175/001-002 |
Daptomycin |
Pfizer Europe MA EEIG |
— |
| Daptomycin Hospira 500 mg powder for solution for injection/infusion EU/1/17/1175/003-004 |
Daptomycin |
Pfizer Europe MA EEIG |
— |
| Daptomycin Xellia 350 mg powder for solution for injection/infusion PA1982/003/001 |
Daptomycin |
Xellia Pharmaceuticals ApS |
Not marketed |
| Daptomycin Xellia 500 mg powder for solution for injection/infusion PA1982/003/002 |
Daptomycin |
Xellia Pharmaceuticals ApS |
Not marketed |
| Darunavir Krka 400 mg Film-coated tablet EU/1/17/1249/001-004 |
Darunavir |
KRKA, d.d., Novo mesto |
— |